XPREZA 100 INJECTION 100 MG/VIAL
Product details
Registration number: SIN15118P
Classification: Prescription Only
Active ingredients: Azacitidine
Strength: 100mg
Dosage form: INJECTION
Route: SUBCUTANEOUS
Registrant: NATCO PHARMA ASIA PTE. LTD.
ATC code: L01BC07
HSA approval date: 23 November 2016
Manufacturer(s):
- Natco Pharma Limited
- Panacea Biotec Pharma Ltd.
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for XPREZA 100 INJECTION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15118P
Classification: Prescription Only
What active ingredients and strength are recorded for XPREZA 100 INJECTION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Azacitidine
Strength: 100mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for XPREZA 100 INJECTION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: SUBCUTANEOUS
Who is the recorded registrant for XPREZA 100 INJECTION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: NATCO PHARMA ASIA PTE. LTD.
Which manufacturers and countries are listed for XPREZA 100 INJECTION 100 MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Natco Pharma Limited
- Panacea Biotec Pharma Ltd.
Manufacturing country/countries: INDIA
Where can I look up XPREZA 100 INJECTION 100 MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15118P or the exact product name XPREZA 100 INJECTION 100 MG/VIAL. The general register link does not preselect this product.
What are the source dates for this XPREZA 100 INJECTION 100 MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this XPREZA 100 INJECTION 100 MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15118P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)